Buy Cardiff Oncology Stock | CRDF Stock Price & Latest News | Public
CRDF

Cardiff Oncology

$0.00 (0.00%)Today
    High Risk
    View Cardiff Oncology (CRDF) stock trends here

    About CRDF

    Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.17
    -0.34
    -0.51
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.15

    Actual EPS
    Q1 2021

    Stats

    Market Cap$385,03M
    Volume85,3k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$25.50
    1 Year Low$0.70
    Open$11.13
    High$11.27
    Low$10.75

    Buy any stock with any amount of money.

    Download the App
    Download the app